In focus · trending topic

Myelodysplastic syndromes

16 stories · following the connections

Geron Corporation Reports Fourth Quarter and Annual 2016 Financial Results

By Nasdaq OMXMar 1, 2017, 9:05 PM UTC

Kura Oncology Doses First Patient in Phase 2 Study of Tipifarnib in Chronic Myelomonocytic Leukemia

By Nasdaq OMXJan 17, 2017, 12:30 PM UTC

Kura Oncology Appoints Steven Stein, M.D. to Board of Directors

By Nasdaq OMXJan 3, 2017, 9:06 PM UTC

Kura Oncology Appoints Steven Stein, M.D. to Board of Directors

By Nasdaq OMXJan 3, 2017, 9:06 PM UTC

Geron Corporation Reports Third Quarter 2016 Financial Results and Recent Events

By Nasdaq OMXNov 3, 2016, 8:05 PM UTC

Geron Provides Update on Imetelstat Trials Being Conducted by Janssen

By Nasdaq OMXSep 12, 2016, 11:30 AM UTC

Kura Oncology to Participate in the 5th Annual Gateway Conference

By Nasdaq OMXSep 2, 2016, 11:30 AM UTC

Geron Announces Initiation of Janssen Phase 2/3 Clinical Trial of Imetelstat in Myelodysplastic Syndromes

By Nasdaq OMXJan 14, 2016, 12:30 PM UTC